Pharmacological profile of the new antihistamines

Clinical and Experimental Allergy Reviews

Volumn 5, Issue 1, 2005, Pages 7-11

  Tillement, Jean Paul ^a  

^a FACULTÉ DE MÉDECINE   (France)

Author keywords

Amphoteric; H1 antihistamines; Levocetirizine; Pharmacokinetics; Therapeutic index; Volume of distribution

Indexed keywords

ASTEMIZOLE; AZITHROMYCIN; CETIRIZINE; DESLORATADINE; ERYTHROMYCIN; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOCONAZOLE; LEVOCETIRIZINE; LORATADINE; MIZOLASTINE; NORASTEMIZOLE; POTASSIUM CHANNEL; TERFENADINE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; CARDIOTOXICITY; CONCENTRATION RESPONSE; DERMATITIS; DOSE RESPONSE; DROWSINESS; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; FOOD DRUG INTERACTION; GRAPEFRUIT JUICE; HEADACHE; HUMAN; NEUROTOXICITY; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REVIEW; SEDATION; SIDE EFFECT; SOMNOLENCE; WEIGHT GAIN;

EID: 22844436333     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.0075.x     Document Type: Review

References (13)

1. 1-receptor antagonists. Biochem Pharmacol 2003; 66:1123-6.
2. Zhang M-Q, Timmerman H. Terfenadine: a mixture of equipotent antihistamine enantiomers without a clear 'isomeric ballast'. Pharm World Sci 1993; 15:186-92.
3. 1-receptor antagonist. J Med Chem 1998; 41:853-63.
4. 1-receptor antagonists. Dermatol Therapy 2000; 13:337-43.
5. Walsh GM, Annunziatto L, Frossard N et al. New insights into the second generation antihistamines. Drugs 2001; 61:207-36.
6. 1 antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002; 32:489-98.
7. Bakker RA, Casarosa P, Timmerman H, Smit MJ, Leurs R. Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors. J Biol Chem 2004; 279:5152-61.
8. Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signalling. Mol Pharmacol 2001; 60:1133-42.
9. 1 antagonists. Receptor affinity versus selectivity. Inflamm Res 2003; 52 (Suppl. 1):S49-50.
10. 1-receptor antagonist properties. Eur J Pharmacol 1990; 183:222.
11. 1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol 1998; 54: 113-21.
12. Holgate ST, Canonica GW, Simons FER et al. Consensus group on new-generation antihistamines (CONGA): present status and recommendations. Clin Exp Allergy 2003; 33:1305-24.
13. Mollimard M, Diquet B, Strolin-Benedetti M. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine, and mizolastine in humans. XXII Congress of the European Academy of Allergy and Clinical Immunology (EAACI), Paris, France, 7-11 June 2003; Abstract book: abstract 962.